Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

The present literature review provides evidence that in patients with low-risk myelodysplastic syndrome and transfusion dependence blood parameters and survival rates can be improved by administration of iron chelators. Dose adequacy and therapy duration underlie clinical efficacy of chelators. Toxi...

Full description

Bibliographic Details

Published in:	Клиническая онкогематология
Main Authors:	SV Gritsaev, II Kostroma, AA Zhernyakova
Format:	Article
Language:	Russian
Published:	Practical Medicine Publishing House 2019-03-01
Subjects:	myelodysplastic syndrome low risk transfusion dependence iron chelators survival
Online Access:	http://bloodjournal.ru/wp-content/uploads/2019/03/2-6.pdf